Magnetic Resonance Elastography of Cardiac Transplant Rejection
- Conditions
- Acute Graft Rejection
- Interventions
- Device: Magnetic Resonance Elastography driver
- Registration Number
- NCT02266914
- Lead Sponsor
- Ohio State University
- Brief Summary
Magnetic Resonance Elastography (MRE) for cardiac transplant patients.
- Detailed Description
Patient will undergo MRE beginning 4-8 weeks post transplant, then with each scheduled cardiac biopsy through 7-8 months post transplant. Results of the MRE will be compared against results of the cardiac biopsy to determine if the non-invasive MRE can predict cardiac transplant rejection.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 9
- Patients must have undergone cardiac transplantation at the Ohio State University Ross Heart Hospital.
- Patients must be able to lie flat on their back in the scanner for up to 60 minutes
- Patient must be able to hold their breath for up to 15 seconds at a time.
- Patients who are claustrophobic
- Patients who are pregnant, due to potential risks to the fetus.
- Patients with any unapproved, non-MRI safe metal/devices in their bodies.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Arm 1 Magnetic Resonance Elastography driver Patients who have received a cardiac transplant at The Ohio State University Ross Heart Hospital will undergo Magnetic Resonance Elastography (MRE) (using a Magnetic Resonance Elastography driver) within 24-48 hours of standard of care biopsy. Results of both will be compared to determine if MRE can successfully predict cardiac transplant rejection.
- Primary Outcome Measures
Name Time Method Cardiac Stiffness With Magnetic Resonance Elastography (MRE) 24-48 hours MRE scans will be performed within 24-48 hours of standard of care cardiac biopsies for patients who have undergone cardiac transplant at The Ohio State University Ross Heart Hospital. Stiffness results from the MRE will be compared to histopathology from the cardiac biopsy to determine if the completely non-invasive MRE can successfully predict transplant rejection.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The Ohio State University Medical Center
🇺🇸Columbus, Ohio, United States